- Report
- April 2024
- 30 Pages
Global
From €2611EUR$2,750USD£2,202GBP
- Report
- October 2024
- 195 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 187 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 195 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 94 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Report
- May 2024
- 131 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 139 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 130 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 134 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1424EUR$1,500USD£1,201GBP
- Report
- January 2025
- 250 Pages
Global
From €4746EUR$4,999USD£4,003GBP
- Report
- February 2025
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- August 2023
- 147 Pages
Global
From €7120EUR$7,500USD£6,006GBP
- Report
- October 2022
- 120 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1424EUR$1,500USD£1,201GBP
- Report
- August 2023
- 201 Pages
Global
From €7120EUR$7,500USD£6,006GBP

Octreotide is a synthetic somatostatin analogue used to treat a variety of gastrointestinal disorders. It is used to reduce the secretion of hormones such as gastrin, secretin, and vasoactive intestinal peptide, which can cause symptoms such as abdominal pain, diarrhea, and flushing. Octreotide is also used to treat acromegaly, a condition caused by excessive growth hormone production. Octreotide is available in both injectable and oral forms, and is often used in combination with other medications.
Octreotide is a widely used drug in the gastrointestinal market, and is often prescribed for the treatment of various gastrointestinal disorders. It is also used to reduce the symptoms of hormone-related conditions such as acromegaly. Octreotide is generally well-tolerated and has few side effects.
Some companies in the Octreotide market include Novartis, Sandoz, and Teva Pharmaceuticals. Show Less Read more